Poseida Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
PSTX
CUSIP
73730P108
Type
Equity
Class
COM
Num filings
101
Total reported value, excl. options
$156 M
Manager Report Date Value ($000) Shares Option Type